Pathways disrupted in human ALS motor neurons identified through genetic correction of mutant SOD1.
暂无分享,去创建一个
Morgan L. Maeder | Derek H. Oakley | Mathew J. Goodwin | R. Handsaker | S. Mccarroll | J. Joung | Robert H. Brown | J. Nemesh | K. Eggan | G. Boulting | Luis A. Williams | Steve S. W. Han | E. Kiskinis | B. Davis-Dusenbery | B. Wainger | Cassidy Mellin | Jackson Sandoe | C. Woolf | F. Merkle | S. Noggle | J. Ichida | D. Oakley | Daniel Paull | S. Thams | R. Moccia | Shravani Mikkilineni | M. Ziller | Stefania Di Costanzo | S. Costanzo | Robert Moccia | Theodore Peng | Nicholas Atwater | Robert H. Brown | M. Goodwin
[1] Robert H. Brown,et al. Intrinsic membrane hyperexcitability of amyotrophic lateral sclerosis patient-derived motor neurons. , 2014, Cell reports.
[2] L. Petrucelli,et al. Targeting RNA Foci in iPSC-Derived Motor Neurons from ALS Patients with a C9ORF72 Repeat Expansion , 2013, Science Translational Medicine.
[3] Nipun A. Mistry,et al. RNA Toxicity from the ALS/FTD C9ORF72 Expansion Is Mitigated by Antisense Intervention , 2013, Neuron.
[4] Robert H. Brown,et al. Amyotrophic lateral sclerosis: Problems and prospects , 2013, Annals of neurology.
[5] E. Kremmer,et al. The C9orf72 GGGGCC Repeat Is Translated into Aggregating Dipeptide-Repeat Proteins in FTLD/ALS , 2013, Science.
[6] Wim Robberecht,et al. The changing scene of amyotrophic lateral sclerosis , 2013, Nature Reviews Neuroscience.
[7] Kevin F. Bieniek,et al. Unconventional Translation of C9ORF72 GGGGCC Expansion Generates Insoluble Polypeptides Specific to c9FTD/ALS , 2013, Neuron.
[8] J. Glass,et al. Cellular toxicity of mutant SOD1 protein is linked to an easily soluble, non-aggregated form in vitro , 2013, Neurobiology of Disease.
[9] M. Cudkowicz,et al. Enhancing clinical trials in neurodegenerative disorders: lessons from amyotrophic lateral sclerosis. , 2012, Current opinion in neurology.
[10] Kenny Q. Ye,et al. An integrated map of genetic variation from 1,092 human genomes , 2012, Nature.
[11] H. Hioki,et al. Drug Screening for ALS Using Patient-Specific Induced Pluripotent Stem Cells , 2012, Science Translational Medicine.
[12] R. Takahashi,et al. Amyotrophic Lateral Sclerosis Model Derived from Human Embryonic Stem Cells Overexpressing Mutant Superoxide Dismutase 1 , 2012, Stem cells translational medicine.
[13] Pablo Cingolani,et al. © 2012 Landes Bioscience. Do not distribute. , 2022 .
[14] G. Daley,et al. Mutant induced pluripotent stem cell lines recapitulate aspects of TDP-43 proteinopathies and reveal cell-specific vulnerability , 2012, Proceedings of the National Academy of Sciences.
[15] Matthew C. Kiernan,et al. Clinical diagnosis and management of amyotrophic lateral sclerosis , 2011, Nature Reviews Neurology.
[16] David Heckerman,et al. A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD , 2011, Neuron.
[17] Bruce L. Miller,et al. Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS , 2011, Neuron.
[18] Pico Caroni,et al. Selective Neuronal Vulnerability in Neurodegenerative Diseases: from Stressor Thresholds to Degeneration , 2011, Neuron.
[19] Hynek Wichterle,et al. A functionally characterized test set of human induced pluripotent stem cells , 2011, Nature Biotechnology.
[20] Joshua M. Korn,et al. Discovery and genotyping of genome structural polymorphism by sequencing on a population scale , 2011, Nature Genetics.
[21] Michael J. Ziller,et al. Reference Maps of Human ES and iPS Cell Variation Enable High-Throughput Characterization of Pluripotent Cell Lines , 2011, Cell.
[22] Feng Zhang,et al. Selection-Free Zinc-Finger Nuclease Engineering by Context-Dependent Assembly (CoDA) , 2010, Nature Methods.
[23] Jan Hellemans,et al. Accurate and objective copy number profiling using real-time quantitative PCR. , 2010, Methods.
[24] P. Caroni,et al. A role for motoneuron subtype–selective ER stress in disease manifestations of FALS mice , 2009, Nature Neuroscience.
[25] D. Brown,et al. Neural KCNQ (Kv7) channels , 2009, British journal of pharmacology.
[26] Chao Tang,et al. Rationalizing translation attenuation in the network architecture of the unfolded protein response , 2008, Proceedings of the National Academy of Sciences.
[27] F. Gage,et al. Non-cell-autonomous effect of human SOD1 G37R astrocytes on motor neurons derived from human embryonic stem cells. , 2008, Cell stem cell.
[28] K. Eggan,et al. Human embryonic stem cell-derived motor neurons are sensitive to the toxic effect of glial cells carrying an ALS-causing mutation. , 2008, Cell stem cell.
[29] Hynek Wichterle,et al. Induced Pluripotent Stem Cells Generated from Patients with ALS Can Be Differentiated into Motor Neurons , 2008, Science.
[30] Ronnie J Winfrey,et al. Rapid "open-source" engineering of customized zinc-finger nucleases for highly efficient gene modification. , 2008, Molecular cell.
[31] Xun Hu,et al. TDP-43 Mutations in Familial and Sporadic Amyotrophic Lateral Sclerosis , 2008, Science.
[32] Junying Yuan,et al. Superoxide dismutase 1 mutants related to amyotrophic lateral sclerosis induce endoplasmic stress in neuro2a cells , 2008, Journal of neurochemistry.
[33] P. Walter,et al. Signal integration in the endoplasmic reticulum unfolded protein response , 2007, Nature Reviews Molecular Cell Biology.
[34] Robert H. Brown,et al. Molecular biology of amyotrophic lateral sclerosis: insights from genetics , 2006, Nature Reviews Neuroscience.
[35] Pablo Tamayo,et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[36] Marjan S. Bolouri,et al. Integrated Analysis of Protein Composition, Tissue Diversity, and Gene Regulation in Mouse Mitochondria , 2003, Cell.
[37] J. Tainer,et al. Insights into Lou Gehrig's disease from the structure and instability of the A4V mutant of human Cu,Zn superoxide dismutase. , 2002, Journal of molecular biology.
[38] J. Rothstein,et al. Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS) , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[39] M. Gurney,et al. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. , 1994, Science.
[40] J. Haines,et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis , 1993, Nature.
[41] A. Hudson,et al. Changes in sizes of cortical and lower motor neurons in amyotrophic lateral sclerosis. , 1991, Brain : a journal of neurology.
[42] Brad T. Sherman,et al. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.
[43] Kai Long,et al. A selective inhibitor of eIF2alpha dephosphorylation protects cells from ER stress. , 2005, Science.
[44] D. Mcilwain. Nuclear and cell body size in spinal motor neurons. , 1991, Advances in neurology.